Form 4 for IBRX ImmunityBio, Inc.
Accepted 2026-07-06 20:26:22 ET · period of report 2026-07-02 · accession 0001529371-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-06 20:26 | 2026-07-02 | IBRX | Cohen Cheryl | Dir | M - OptEx | $2.98 | +56.0K | 256.6K | +28% | +$166.8K |
| DT | 2026-07-06 20:26 | 2026-07-02 | IBRX | Cohen Cheryl | Dir | S - Sale+OE | $9.50 | -131.2K | 125.4K | -51% | -$1.25M |
| DT | 2026-07-06 20:26 | 2026-07-02 | IBRX | Cohen Cheryl | Dir | M - OptEx | $0.00 | -56.0K | 112.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-02 | M | A | 55,979 | $2.98 | 256,596 | D | — | — | |
| 2 | Common | Common Stock | 2026-07-02 | S | D | 131,210 | $9.50 | 125,386 | D | — | — | (F1) The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 27, 2026. (F2) Represents the weighted average share price of an aggregate total of 131,210 shares sold in the price range of $9.50 to $9.52 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the "Issuer") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Derivative | Stock Option (right to buy) | 2026-07-02 | M | D | 55,979 | $0.00 | 111,958 | D | $2.98 · 2023-06-12 to 2032-06-14 | 55,979 Common Stock |